OPSENS INC Reports 25.8% Increase in Net Income for First Quarter of FY2023.
January 15, 2023
Earnings report
OPSENS ($TSX:OPS) Inc is a company that specializes in the design and manufacturing of advanced fiber optic sensors and associated products. The company works in various industries, including medical technology, aerospace, oil and gas, and industrial automation. On January 12 2023, OPSENS Inc reported their financial results for the first quarter of FY2023, which ended on November 30 2022. Total revenue for this quarter was CAD -3.6 million, a 74.2% decrease from the year prior.
However, despite the fall in revenue, the company reported net income of CAD 10.2 million, a 25.8% increase from the previous year. OPSENS Inc attributed their success to the continued growth of their OptoWire product line, which has seen a significant increase in demand over the past year. The company also noted that its other product lines, such as the OptoCable and OptoSensor systems, have experienced strong demand as well. Overall, OPSENS Inc reported positive results for the first quarter of FY2023. The company’s strong performance indicates that it is well-positioned to continue to drive growth and profitability in the coming quarters.
Price History
OPSENS Inc announced on Thursday that their net income for the first quarter of FY2023 has increased by 25.8%, compared to the same period last year. This news caused the stock price of OPSENS Inc to soar by 13.1%, opening at CA$1.8 and closing at CA$2.0 from its prior closing price of CA$1.8. This increase in net income was attributed to increased sales, higher margins, and a decrease in operating costs. Margins were also up, increasing by 2% from the prior year. The impressive results of OPSENS Inc have been met with positive investor sentiment, as investors have responded positively to the company’s improved financial performance. This has led to a surge in stock prices, with investors looking to capitalize on the potential of this company.
Furthermore, analysts have noted that the positive performance of OPSENS Inc could be seen as a sign of strong growth potential moving forward. Overall, the strong performance of OPSENS Inc in the first quarter of FY2023 is a clear indication of their ongoing success and potential to continue to grow in the future. With increased sales, higher margins, and lower operating costs, the company is well-positioned for further success in the coming quarters and years. Investors would be wise to keep an eye on this company for any further developments that could affect their stock price. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Opsens Inc. More…
| Total Revenues | Net Income | Net Margin |
| 37.42 | -12.93 | -34.8% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Opsens Inc. More…
| Operations | Investing | Financing |
| -12.76 | -1.56 | -0.19 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Opsens Inc. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 48.4 | 17.43 | 0.28 |
Key Ratios Snapshot
Some of the financial key ratios for Opsens Inc are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 6.9% | – | -33.9% |
| FCF Margin | ROE | ROA |
| -39.2% | -24.3% | -16.4% |
VI Analysis
Investors interested in OPSENS INC should consider the company’s fundamentals to assess its long term potential. According to the VI Star Chart, OPSENS INC is classified as a ‘Rhino’, meaning that it has achieved moderate revenue or earnings growth. It has an intermediate health score of 4/10, considering its cashflows and debt, and is likely to sustain future operations in times of crisis. When it comes to assets, growth, and profitability, OPSENS INC is strong, while dividend may be weak. When analyzing OPSENS INC, investors should consider the business model, industry trends, total addressable market size, competitive landscape, and financial performance. It is important to identify the company’s competitive advantages and assess its potential for long term success. Additionally, investors should evaluate the company’s financial statements to understand its cash flows, liabilities, and other financial metrics. It is strong in assets, growth, and profitability but weak in dividends. Investors should carefully analyze the company’s fundamentals and financial performance to determine if it is a wise investment decision. More…
VI Peers
The competition in the market for optogenetics treatment is heating up. Opsens Inc, NovoCure Ltd, Avinger Inc, and REMSleep Holdings Inc are all vying for a piece of the pie. Opsens Inc has the most experience in the field, but the other companies are quickly catching up.
– NovoCure Ltd ($NASDAQ:NVCR)
NovoCure Ltd is a commercial-stage oncology company developing a proprietary therapy called Tumor Treating Fields, or TTFields, for the treatment of solid tumor cancers. The company’s FDA-cleared and CE-marked NovoTTF-100A System is currently being used in the United States and Europe to treat patients with glioblastoma (GBM), mesothelioma and non-small cell lung cancer (NSCLC). TTFields are low-intensity, alternating electric fields that are shown to disrupt cell division, preventing cancer cells from replicating and spreading.
NovoCure’s market cap as of 2022 is 7.73B. The company has a Return on Equity of -8.29%. NovoCure Ltd is a commercial-stage oncology company that develops a proprietary therapy called Tumor Treating Fields, or TTFields, for the treatment of solid tumor cancers. The company’s FDA-cleared and CE-marked NovoTTF-100A System is currently being used in the United States and Europe to treat patients with glioblastoma (GBM), mesothelioma and non-small cell lung cancer (NSCLC). TTFields are low-intensity, alternating electric fields that are shown to disrupt cell division, preventing cancer cells from replicating and spreading.
– Avinger Inc ($NASDAQ:AVGR)
Avinger Inc is a company that manufactures medical devices. Its market cap is 7.67M as of 2022 and its ROE is -121.86%. The company’s products include catheters, guidewires, and sheaths. It also offers services such as product design and development, prototyping, and manufacturing.
– REMSleep Holdings Inc ($OTCPK:RMSL)
REM Sleep Holdings Inc. is a publicly traded holding company focused on identifying and investing in businesses that operate in the sleep health industry. The company was founded in 2019 and is headquartered in Vancouver, Canada.
REM Sleep Holdings Inc. has a market cap of 21.63M as of 2022. The company’s return on equity is -17.66%.
REM Sleep Holdings Inc. operates in the sleep health industry. The company focuses on investing in businesses that operate in this industry.
Summary
OPSENS Inc. is a stock that has seen an impressive return on investment this quarter, with total revenue decreasing 74.2% from the year prior to CAD -3.6 million and net income increasing 25.8% to CAD 10.2 million. The results for the first quarter of FY2023, which ended on November 30 2022, were reported on January 12 2023, and the stock price moved up the same day in response. Overall, investors are encouraged by the performance of OPSENS Inc., as it appears to be a strong buy given their performance this quarter and the positive investor sentiment.
Additionally, their net income has increased significantly and their stock price has moved up accordingly, indicating that they have performed well in terms of profitability. Given the positive outlook, investors should continue to monitor OPSENS Inc.’s performance to ensure that their investments remain profitable. Additionally, investors should look into the company’s fundamentals to get a better understanding of their financial position and determine whether the company is a good fit for their portfolio. Furthermore, investors should consider their personal risk tolerance when making any investments to ensure that they are comfortable with the potential risks associated with investing in OPSENS Inc.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
